Table 2.
Comparison of resuscitation treatments
| Treatment administered |
Treatment dose* |
||||||
|---|---|---|---|---|---|---|---|
| Agent | CFA, n (%) | Control, n (%) | Pa | Agent | CFA, median (mean) | Control, median (mean) | Pb |
| Electricity, total (joules) | 11 (100) | 11 (100) | NS | Electricity, total (joules) | 600 (582) | 600 (636) | NS |
| Epinephrine | 11 (100) | 11 (100) | NS | Epinephrine (mg) | 3 (3) | 4 (3) | 0.45 |
| Vasopressin | 3 (27) | 3 (27) | NS | Vasopressin (units) | 40 (40) | 40 (40) | NS |
| Atropine | 7 (64) | 3 (27) | 0.20 | Atropine (mg) | 1 (0.65) | 0.75 (0.75) | 0.17 |
| Lidocaine | 3 (27) | 3 (27) | NS | Lidocaine (mg) | 200 (183) | 150 (150) | 0.90 |
| Amiodarone | 4 (36) | 7 (64) | 0.39 | Amiodarone (mg) | 450 (412) | 450 (386) | 0.37 |
| Sodium bicarbonate | 2 (18) | 2 (18) | NS | Sodium bicarbonate (mEq) | 89 (89) | 89 (89) | NS |
| Calcium gluconate | 2 (18) | 2 (18) | NS | Calcium gluconate (g) | 1 (1) | 1 (1) | NS |
| Magnesium sulfate | 1 (9) | 1 (9) | NS | Magnesium sulfate (g) | 1 (1) | 1 (1) | NS |
*Due to small sample size and low treatment numbers for any given therapy, the mean and median doses only include patients who received the treatment. The sample size for those calculations is reported on the left-hand side of the table, aFisher’s exact test, bWilcoxon test. CFA: Cardio first angel, NS: Not significant